Kamlesh Khunti to Benzhydryl Compounds
This is a "connection" page, showing publications Kamlesh Khunti has written about Benzhydryl Compounds.
Connection Strength
0.208
-
Sodium-glucose co-transporter-2 inhibitors and cardiovascular outcome studies in people with type 2 diabetes: From efficacy to effectiveness. Diabetes Obes Metab. 2018 04; 20(4):763-765.
Score: 0.139
-
SGLT2 inhibitors and renal outcomes in type 2 diabetes with or without renal impairment: A systematic review and meta-analysis. Prim Care Diabetes. 2018 06; 12(3):265-283.
Score: 0.035
-
Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors). Circulation. 2017 Jul 18; 136(3):249-259.
Score: 0.034